FFO
TNGX icon

Fortitude Family Office’s Tango Therapeutics TNGX Stock Holding History

Fortitude Family Office’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.69K Buy
310
+180
+138% +$4.45K ﹤0.01% 788
2026
Q1 		$2.72K Buy
+130
New +$1.81K ﹤0.01% 1165
2025
Q2 		– Sell
-1,198
Closed -$1.64K – 2133
2025
Q1 		$1.64K Hold
1,198
– – ﹤0.01% 950
2024
Q4 		$3.7K Buy
1,198
+569
+90% +$2.64K ﹤0.01% 915
2024
Q3 		$4.84K Hold
629
– – ﹤0.01% 797
2024
Q2 		$5.4K Buy
629
+139
+28% +$1.07K ﹤0.01% 564
2024
Q1 		$3.89K Hold
490
– – ﹤0.01% 693
2023
Q4 		$4.85K Buy
+490
New +$4.25K ﹤0.01% 652

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Fortitude Family Office's TNGX Position: Q2 2026 in Review

Fortitude Family Office increased its Tango Therapeutics (TNGX) stake by 138% in Q2 2026, buying an estimated $4.45K and bringing the position to 310 shares worth $9.69K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Fortitude Family Office first reported a position in TNGX in Q4 2023 and has held it in 8 quarters since. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Fortitude Family Office held 310 shares of Tango Therapeutics worth $9.69K as of Q2 2026.
  • Fortitude Family Office bought 180 Tango Therapeutics shares in Q2 2026, an estimated $4.45K.
  • Tango Therapeutics made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #788 holding.
  • Fortitude Family Office first reported a position in Tango Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.